Resource Center
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Contact UsLog InLog Out
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Equity Research
Research Reports
Quantum BioPharma
Quantum BioPharma
Reports
Quantum BioPharma Reports Solid FY 2025 Earnings, Extends Cash Runway into 2028
March 31, 2026
KAREN STERLING, PhD, CFA
Download Report
Quantum BioPharma’s Lucid-MS Multple Sclerosis Asset Progressing Toward Proof-of- Concept Studies in Humans
August 29, 2025
KAREN STERLING, PhD, CFA, NEEL DAHAKE, TEJAS PRAKASH
Download Report
Securities offered through Kingswood Capital Partners, LLC Member FINRA/SIPC. Advisory services offered through Kingswood Wealth Advisors an SEC registered investment advisor.
Kingswood USNews & MediaAbout UsLinkedInContact Us